Mersana logo

Mersana Therapeutics

HQ
Cambridge, Massachusetts, USA
163 Total Employees
Year Founded: 2001

Similar Companies Hiring

Pharmaceutical • Healthtech • Biotech • Big Data • Artificial Intelligence
New York, NY
140 Employees
Software • Healthtech • Biotech • Big Data • Artificial Intelligence
3 Offices
450 Employees
Pharmaceutical • Natural Language Processing • Machine Learning • Healthtech • Biotech • Artificial Intelligence
42 Offices
121990 Employees
At Mersana, we have a passion for advancing therapies to make a significant impact in the lives of people living with cancer.

Mersana Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel antibody-drug conjugates (ADCs) and driven by the knowledge that patients are waiting for new treatment options. The company has developed proprietary cytotoxic (Dolasynthen) and immunostimulatory (Immunosynthen) ADC platforms that are generating a pipeline of wholly-owned and partnered product candidates with the potential to treat a range of cancers. Its pipeline includes XMT-1660, a Dolasynthen ADC targeting B7-H4, and XMT-2056, an Immunosynthen ADC targeting a novel epitope of human epidermal growth factor receptor 2 (HER2).

Mersana Therapeutics Offices

OnSite Workspace

Employees work from physical offices.

Typical time on-site: None
HQCambridge, Massachusetts, USA